Differential Chemotherapeutic Sensitivity for Breast Tumors With “BRCAness”: A Review-Reference-Cited by-同舟云学术

Differential Chemotherapeutic Sensitivity for Breast Tumors With “BRCAness”: A Review

Published:2013-07-23 Issue:8 Volume:18 Page:909-916
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Chalasani Pavani¹,Livingston Robert¹

Affiliation:

1. The University of Arizona Cancer Center, Tucson, Arizona, USA

Abstract

Learning Objectives Explain the concept of sporadic “BRCAness” in breast tumors. Describe the current status, obstacles, and future direction for utility of sporadic “BRCAness” in breast tumors.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0039

Reference58 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Breast and ovarian cancer;Wooster;N Engl J Med,2003

3. Hallmarks of ‘BRCAness’ in sporadic cancers;Turner;Nat Rev Cancer,2004

4. Targeting the DNA repair defect of BRCA tumours;Turner;Curr Opin Pharmacol,2005

5. Functions of BRCA1 and BRCA2 in the biological response to DNA damage;Venkitaraman;J Cell Sci,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response;Exploration of Targeted Anti-tumor Therapy;2024-02-28

2. Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC);Journal of Clinical Medicine;2023-02-15

3. Bladder cancer organoids as a functional system to model different disease stages and therapy response;2022-04-01

4. Platinum-based systematic therapy in triple-negative breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-01

5. Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer;Cancers;2021-09-16